Oracle Investment Management Inc Vir Biotechnology, Inc. Transaction History

Oracle Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$21.19 - $40.01 $18.2 Million - $34.4 Million	-861,008 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$30.97 - $54.03 $9.92 Million - $17.3 Million	-320,349 Reduced 27.12%	861,008 $36.1 Million
Q3 2021 Nov 15, 2021	BUY	$34.9 - $54.54 $16.6 Million - $26 Million	475,871 Added 67.45%	1,181,357 $51.4 Million
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $9.89 Million - $13 Million	255,155 Added 56.66%	705,486 $33.4 Million
Q1 2021 May 17, 2021	BUY	$26.34 - $83.07 $11.9 Million - $37.4 Million	450,331 New	450,331 $23.1 Million

246

109M

350K

150K

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $743M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oracle Investment Management Inc with notifications on news.